Therapeutic potential of nesiritide (recombinant b-type natriuretic peptide) in the treatment of heart failure

Bibliography

• SUDOH T, KANGAWA K, MINAMINO N, MATSUO H: A new natriuretic peptide in porcine brain. Nature (1988) 332:78–81.
   PubMed Web of Science ®Google Scholar
• GARDNER DG: Molecular and cellular biology of the natriuretic peptides. Heart Fail. (1996) 12(2):37–54.
   Google Scholar
• •Good review of processes which control peptide expression.
   Google Scholar
• HOSODA K, NAKAO K, MUKOYAMA M et al.: Expressionof brain natriuretic peptide gene in human heart: Production in the ventricle. Hypertension (1991) 17:1152–1156.
   PubMed Web of Science ®Google Scholar
• NAKAOKA H, IMATAKA K, AMANO M, FUJII J, ISHIBASHI M, YAMAJI T: Plasma levels of atrial natriuretic factor in patients with congestive heart failure. N Engl. J. Med. (1985) 313:892–893.
   PubMed Web of Science ®Google Scholar
• LANG RE, DIETZ R, MERKEL A, UNGER T, RUSKOAHO H,GANTEN D: Plasma atrial natriuretic peptide values in cardiac disease. J. Hypertens. (1986) 4 (Suppl. 2):S119–123.
   Google Scholar
• TSUTAMOTO T, MAEDA Y, WADA A, ADACHI T, NAKAMURA Y, KINOSHITA M: Plasma brain natriuretic peptide concentration as a prognostic predictor in patients with chronic congestive heart failure. Circula-tion (1993) 88(4):I–26.
   Web of Science ®Google Scholar
• YAMAMOTO K, BURNETT J, JOUGASAKI M et al.: Superi-ority of brain natriuretic peptide as a hormonal marker of systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension (1996) 28:988-994. WONG SK, GARBERS DL: Receptor guanylyl cyclases. J. Clin. Invest. (1992) 90:299-305. A technically-detailed review. KOHNO M, YASUNARI K, YOKOKAWA K etal.: Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin-II and thrombin of cultured human endothelial cells. J. Clin. Invest. (1991) 87:1999–2004.
   Google Scholar
• MUKOYAMA M, NAKAO K, HOSODA K et al.: Brain natriuretic peptide as a novel cardiac hormone in humans. J. Clin. Invest. (1991) 87:1402–1412.
   PubMed Web of Science ®Google Scholar
• NORMAN JA, LITTLE D, BOLGAR M et al: Degradation of brain natriuretic peptide by neutral endopeptidase: Species specific sites of proteolysis determined by mass spectrometry. Biochem. Biophys. Res. Commun. (1991) 175:22–30.
   PubMed Web of Science ®Google Scholar
• KENNY AJ, BOURNE A, INGRAM J: Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide, and some C-receptor ligands by endopeptidase 24.11. Biochem. J. (1993) 291:83–88.
   PubMed Web of Science ®Google Scholar
• SEYMOUR A, ASAAD MM, ABBOA-OFFEI BE, ROVNYAK PL, FENNELL S, ROGERS WL: Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats. J. Pharmacol Exp. Ther. (1992) 262:60–70.
   Google Scholar
• ENGEL A, SCHOENFELD J, LOWE D: A single residue determines the distinct pharmacology of rat and human natriuretic peptide receptor-C. J. Biol. Chem. (1994) 269:17005–17008.
   PubMed Web of Science ®Google Scholar
• PROTTER AA, WALLACE AM, FERRARIS VA, WEISHAAR RE:Relaxant effect of human brain natriuretic peptide on human artery and vein tissue. Am. J. Hypertens. (1996) 9:432–436.
   PubMed Web of Science ®Google Scholar
• RODEN RL, ASANO K, WICHMAN S, HOOVER E, BRISTOW MR, ABRAHAM WT: Inotropic effect of human B-type natriuretic peptide in the failing human heart. J. Cardiac Fail. (1998) 4 (Suppl. 0:19.
   Google Scholar
• CLAVELL AL, STINGO AJ, AARHUS LL, BURNETT JC: Biological actions of brain natriuretic peptide in thoracic inferior vena cava constriction. Am. J. Physic)]. (1993) 265:R1416–1422.
   Web of Science ®Google Scholar
• CLEMENS LE, ALMIREZ RG, BAUDOUIN KA, GROSSBARD EB, PROTTER AA: Human brain natriuretic peptide reduces blood pressure in normotensive rabbits and acute noradrenaline-induced hypertensive rabbits. Am. J. Hypertens. (1997) 10:654–661.
   PubMed Web of Science ®Google Scholar
• HOFFMAN A, GROSSMAN E, KEISER HR: Increased plasma levels and blunted effects of brain natriuretic peptide in rats with congestive heart failure. Am. J. Hypertens. (1991) 4(7):597–601.
   PubMed Web of Science ®Google Scholar
• CLARKSON PBM, WHEELDON NM, MACLEOD C, COUTIE W, MACDONALD TM: Brain natriuretic peptide: Effect on left ventricular filling patterns in healthy subjects. Sci. (1995) 88:159–164.
   Web of Science ®Google Scholar
• CLARKSON PB, WHEELDON NM, MACFAYDEN RJ, PRINGLE SD, MACDONALD TM: Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure. Circulation (1996) 93(11)2037–2042.
   Google Scholar
• MCGREGOR A, RICHARDS AM, ESPINER EA, YANDLE T,IKRAM H: Brain natriuretic peptide administered to man: Actions and metabolism. J. Clin. Endocrinol. Metab. (1990) 70:1103–1107.
   PubMed Web of Science ®Google Scholar
• HOLMES SJ, ESPINER EA, RICHARDS AM, YANDLE TG, FRAMPTON C: Renal, endocrine and hemodynamic effects of human natriuretic peptide in normal man. J. Endocrinol. Metab. (1993) 76:91–96.
   PubMed Web of Science ®Google Scholar
• LAVILLA G, FRONZAROLI C, LAZZERI C et al.: Cardiovas-cular and renal effects of low dose brain natriuretic peptide in man. J. Clin. Endocrinol. Metab. (1994) 78 (5):1166–1171.
   PubMed Web of Science ®Google Scholar
• OKUMURA K, YASUE H, FUJII H et al.: Effects of brain (B-type) natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in humans: Comparison with effects on systemic hemodynamic variables. J. Am. Coll. Cardiol. (1995) 25 (2):342–348.
   PubMed Web of Science ®Google Scholar
• CARGILL R, STRUTHERS A, LIPWORTH B: Comparative effects of atrial natriuretic peptide and brain natriuretic peptide on the aldosterone and pressor responses to angiotensin II in man. Clin. Sci. (1995) 88 (1):81–86.
   PubMed Web of Science ®Google Scholar
• YOSHIMURA M, YASUE H, MORITA E et al.: Hemody-namic, renal and hormonal responses to brain natriuretic peptide infusion in patients with conges-tive heart failure. Circulation (1991) 84:1581–1588.
   PubMed Web of Science ®Google Scholar
• ABRAHAM WT, LOWES BD, FERGUSON DA et al.: Systemic hemodynamic, neurohormonal, and renal
   Google Scholar
• MARCUS LS, HART D, PACKER M et al: Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure: A double-blind, placebo-controlled, random-ized crossover trial. Circulation (1996) 94:3184–3189.
   PubMed Web of Science ®Google Scholar
• MILLS RM Jr, LEJEMTEL T, CHATTERJEE K et al.: Hemody-namic effects of a 24 hour infusion of B-type natriuretic peptide (Natrecor®) in patients with decompensated heart failure. J. Am. Coll. Cardiol. (1997) 29(Suppl. A):286A.
   Google Scholar
• •Pivotal study.
   Google Scholar
• LEJEMTEL TH, BOURGE RC, JOHNSON AD, HORTON DP, COLUCCI WS: Recombinant human B-type natriuretic peptide improves symptoms and hemodynamics in patients with acutely decompensated CHF. J. Am. Coll. Cardiol. (1998) 32 (Suppl. A):83A.
   Google Scholar
• •Pivotal study.
   Google Scholar
• BOURGE RC, ABRAHAM WT, WAGONER LE, HORTON DP:Nesiritide improves hemodynamics in patients with acutely decompensated heart failure: Hemodynamic subgroup analysis. Circulation (1998) 98(17)I–578.
   Google Scholar
• ELKAYAM U, NEIBAUR M, HAUGHT WH, HORTON DP:Safety study of nesiritide (human B-type natriuretic peptide) for the treatment of hospitalized patients with acutely decompensated CHF. J. Cardiac Fail. (1998) 4(3)Suppl 1: 40.
   Google Scholar
• •This study closely duplicated clinical practice patterns.
   Google Scholar
• HOBBS RE, MILLER LW, BOTT-SILVERMAN C, JAMES KB, RINCON G, GROSSBARD EB: Hemodynamic effects of a single intravenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. (1996) 78:896–901.
   PubMed Web of Science ®Google Scholar
• CODY RJ: Repetitive bolus administration of brain natriuretic peptide reduces cardiac filling pressures in human heart failure. J. Am. Coll. Cardiol. (1996) 27:70A
   Google Scholar
• CARGILL RI, CLARKSON PBI, MACDONALD TM et al.: Profound vagal reactions to brain natriuretic peptide. Mol Med. (1995) 73:149–150.
   Web of Science ®Google Scholar
• BURGER A, JOHNSON A, HORTON DP: Effect of nesiritide versus dobutamine on cardiovascular adverse events during treatment of acute heart failure. Circulation (1998) 98(17):I–578.
   Web of Science ®Google Scholar